Please use this identifier to cite or link to this item:
http://sgc.anlis.gob.ar/handle/123456789/1619| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2020-06-21T16:45:31Z | - |
| dc.date.available | 2020-06-21T16:45:31Z | - |
| dc.date.issued | 2020-06-18 | - |
| dc.identifier.uri | https://www.filo.news/ciencia/Investigadores-de-la-UNSAM-desarrollaron-un-suero-hiperinmune-contra-COVID-19-20200618-0021.html | - |
| dc.identifier.uri | http://sgc.anlis.gob.ar/handle/123456789/1619 | - |
| dc.description.abstract | El tratamiento, llevado a cabo enteramente en la Argentina y por científicos Argentinos, persigue la inmunización pasiva y consiste en administrar anticuerpos a los pacientes contra el agente infeccioso, produciendo su bloqueo y evitando que se propague. | en_US |
| dc.publisher | Filo.news | en_US |
| dc.subject | COVID19 | en_US |
| dc.subject | Medios de Comunicación | en_US |
| dc.subject | Suero Terapéutico COVID19 | en_US |
| dc.title | Investigadores de la UNSAM desarrollaron un suero hiperinmune contra COVID-19 | en_US |
| dc.type | Medios | en_US |
| item.openairetype | Medios | - |
| item.grantfulltext | open | - |
| item.cerifentitytype | Publications | - |
| item.fulltext | With Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| Appears in Collections: | ANLIS frente a la epidemia COVID-19 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Investigadores de la UNSAM desarrollaron un suero hiperinmune contra COVID.pdf | 424.4 kB | Adobe PDF |  View/Open |
Page view(s)
111
checked on Jun 16, 2025
Download(s)
11
checked on Jun 16, 2025
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.